Brief: 9 Meters Biopharma Announces Positive Preclinical Data For NM-102, A Gut Microbiome Modulator In Immune Checkpoint Inhibitor Failure Model

9 Meters Biopharma

16/11/2020 12:56

Nov 16 (Reuters) - 9 Meters Biopharma Inc  NMTR.O :
    * 9 METERS BIOPHARMA INC - ANNOUNCES POSITIVE PRECLINICAL
DATA FOR
NM-102, A GUT MICROBIOME MODULATOR IN AN IMMUNE CHECKPOINT
INHIBITOR FAILURE MODEL
    * 9 METERS BIOPHARMA INC - INTENDS TO MOVE FORWARD WITH AN
IND-ENABLING PATHWAY TO FURTHER DEVELOP NM-102
    * 9 METERS BIOPHARMA INC - NM-102 SHOWS POSITIVE EFFECT IN
AN
AGGRESSIVE IMMUNE CHECKPOINT INHIBITOR FAILURE MELANOMA MODEL

Source text for Eikon: [ID:https://bit.ly/2IF0NXy]
Further company coverage:  NMTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))